Novo CEO pressed by Senate to chop charges of obesity, diabetes medications CEO Lars Fruergaard Jørgensen informed lawmakers the corporation would take into account new talks with insurers with regards to the listing price ranges of Wegovy and copyright when they pledge to maintain the medicines on their formularies. Listen https://dave-s-hot-chicken-nutrit16059.webbuzzfeed.com/31178469/healthcare-news-secrets